Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

Press releases published on October 1, 2026

19 minutes ago

AI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech Investment

Indeterminate GlobeNewswire

28 minutes ago

Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts

Indeterminate GlobeNewswire

29 minutes ago

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Indeterminate GlobeNewswire

38 minutes ago

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Indeterminate GlobeNewswire

38 minutes ago

Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care

Indeterminate GlobeNewswire

38 minutes ago

Crohn et Colite Canada investit 1,5 million de dollars dans la recherche sur les MII et les soins futurs

Indeterminate GlobeNewswire

43 minutes ago

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

Indeterminate GlobeNewswire

43 minutes ago

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

Indeterminate GlobeNewswire

an hour ago

Novonesis completes acquisition of MicroBioGen, strengthening its yeast capabilities

Indeterminate GlobeNewswire

an hour ago

American Kidney Fund and IgA Nephropathy Foundation Advocate on Capitol Hill for Rare Kidney Disease Legislation

Indeterminate GlobeNewswire

an hour ago

Doheny Eye Institute Experts to Share Groundbreaking Insights at the American Academy of Ophthalmology 2026 Annual Meeting

Indeterminate GlobeNewswire

an hour ago

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

Indeterminate GlobeNewswire

an hour ago

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

an hour ago

Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28

Indeterminate GlobeNewswire

an hour ago

AONN+ and Manta Cares Partner to Equip Oncology Navigators With AI Tool Purpose-Built for Cancer Patients

Indeterminate GlobeNewswire

an hour ago

Legato Frames, the World’s First AI-Based Hearing Glasses, Are Now Available in the U.S.

Indeterminate GlobeNewswire

an hour ago

Vima Therapeutics to Present New Research at the 2026 International Congress of Parkinson’s Disease and Movement Disorders

Indeterminate GlobeNewswire

an hour ago

Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma

Indeterminate GlobeNewswire

an hour ago

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)

Indeterminate GlobeNewswire

an hour ago

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Indeterminate GlobeNewswire